Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets.

Details

Language :

English

ISSN :

03445704

Volume :

67

Issue :

1

Database :

Academic Search Index

Journal :

Cancer Chemotherapy & Pharmacology

Publication Type :

Academic Journal

Accession number :

104977858

Full Text :

https://doi.org/10.1007/s00280-010-1280-6